Longboard Pharmaceuticals Inc

NAS:LBPH (USA)  
$ 21.50 +1.06 (+5.19%) 10:08 PM EST
At Loss
P/B:
9.37
Market Cap:
$ 722.70M
Enterprise V:
$ 693.71M
Volume:
589.34K
Avg Vol (2M):
2.02M
Volume:
589.34K
At Loss
Avg Vol (2M):
2.02M

Business Description

Longboard Pharmaceuticals Inc
NAICS : 541714 SIC : 2834
ISIN : US54300N1037
Description
Longboard Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases. The company is working to improve a portfolio of centrally acting product candidates designed to be selective for specific G protein-coupled receptors (GPCRs). The company is evaluating LP352, an oral, centrally acting 5-hydroxytryptamine 2C (5-HT2C) receptor superagonist, with negligible observed impact on 5-HT2B and 5-HT2A receptor subtypes, in development for the potential treatment of seizures associated with a broad range of developmental and epileptic encephalopathies.
Name Current Vs Industry Vs History
Cash-To-Debt 111.59
Equity-to-Asset 0.88
Debt-to-Equity 0.01
Debt-to-EBITDA -0.01
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 60.79
9-Day RSI 54.52
14-Day RSI 54.81
6-1 Month Momentum % 320.5
12-1 Month Momentum % 418.01

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 8.69
Quick Ratio 8.69
Cash Ratio 8.35

Dividend & Buy Back

Name Current Vs Industry Vs History
Shareholder Yield % -4.02

Financials (Next Earnings Date:2024-03-01 Est.)

LBPH's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:LBPH

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Longboard Pharmaceuticals Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -2.421
Beta 0
Volatility % 278.19
14-Day RSI 54.81
14-Day ATR ($) 1.954576
20-Day SMA ($) 20.999
12-1 Month Momentum % 418.01
52-Week Range ($) 3.6 - 28.15
Shares Outstanding (Mil) 35.36

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Longboard Pharmaceuticals Inc Filings

Filing Date Document Date Form
No Filing Data

Longboard Pharmaceuticals Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Longboard Pharmaceuticals Inc Frequently Asked Questions

What is Longboard Pharmaceuticals Inc(LBPH)'s stock price today?
The current price of LBPH is $21.50. The 52 week high of LBPH is $28.15 and 52 week low is $3.60.
When is next earnings date of Longboard Pharmaceuticals Inc(LBPH)?
The next earnings date of Longboard Pharmaceuticals Inc(LBPH) is 2024-03-01 Est..
Does Longboard Pharmaceuticals Inc(LBPH) pay dividends? If so, how much?
Longboard Pharmaceuticals Inc(LBPH) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1